Compounds > n-leucyldoxorubicin
Page last updated: 2024-08-25

n-leucyldoxorubicin and Mucositis, Oral

n-leucyldoxorubicin has been researched along with Mucositis, Oral in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baurain, R; Bugat, R; Canal, P; de Forni, M; Magis, A; Marty, M; Pujade-Lauraine, E; Ramon, M; Robert, J; Tresca, P1

Trials

1 trial(s) available for n-leucyldoxorubicin and Mucositis, Oral

ArticleYear
Human pharmacokinetics of N-L-leucyl-doxorubicin, a new anthracycline derivative, and its correlation with clinical toxicities.
    Clinical pharmacology and therapeutics, 1992, Volume: 51, Issue:3

    Topics: Dose-Response Relationship, Drug; Doxorubicin; Drug Evaluation; Humans; Leukocyte Count; Platelet Count; Regression Analysis; Stomatitis

1992